CTEC Convatec Group PLC

3.527USD268.20 GBp · LSE-0.67%Mkt Cap: 6.73B USDP/E: 53.64

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company of…

Insiders, last 90 days39 buys
Institutional holders11 on file

Key Statistics

Company
Market Cap6.73B USD
Enterprise Value9.06B USD
Revenue (TTM)2.49B USD
Gross Profit1.37B USD
Net Income (TTM)175.00M USD
Revenue/Share1.26 USD
Last Price3.527 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10.0K
CountryGB
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINGB00BD3VFW73
Valuation
P/E (Trailing)53.64
P/E (Forward)15.64
PEG0.66
EV/EBITDA11.84
EV/Revenue3.64
P/S2.06
P/B4.91
EPS (TTM)0.05 USD
EPS (Forward)0.17 USD
52W Range
0.000098% of range3.585
52W High3.585 USD
52W Low0.0000 USD
Profitability
Gross Margin56.21%
Oper. Margin16.30%
EBITDA Margin23.36%
Profit Margin7.18%
ROE11.53%
ROA4.63%
ROIC9.90%
ROCE12.20%
Growth
Revenue Growth4.40%
Earnings Growth-47.10%
Cash Flow & Leverage
Operating CF470.00M USD
CapEx (TTM)185.00M USD
FCF Margin7.34%
FCF Yield2.71%
Net Debt1.65B USD
Net Debt/EBITDA2.83
Net Debt/FCF9.02
Balance Sheet
Debt/Equity1.00
Current Ratio1.93
Quick Ratio1.06
Book Value/Sh0.55 USD
Cash/Share0.05 USD
Dividends
Fwd Div Rate0.0008 USD
Trail. Div Rate0.0010 USD
Div. Yield2.05%
5Y Avg Yield2.13%
Payout Ratio116.49%
Ex-Div DateAug 20, 2026
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.116 USD
Upside (mean)+16.7%
Target Range3.076 USD – 5.011 USD
3.076+16.7% to mean5.011
# Analysts20
Ownership
Shares Out.1.91B
Float1.95B
Insiders0.20%
Institutions87.92%
Technical
SMA 503.056 (+15.4%)
SMA 2002.946 (+19.7%)
Beta0.73
S&P 52W Chg12.00%
Avg Vol (30d)9.11M
Avg Vol (10d)9.74M
Technical Indicators
RSI (14)68.6
MACD7.6402
MACD Signal6.7260
MACD Hist.+0.9142
BB Upper3.503 USD
BB Middle3.296 USD
BB Lower3.089 USD
BB Width12.58%
ATR (14)0.0933 USD
Vol Ratio (20d)0.88x

About Convatec Group (LON: CTEC)

›

Convatec Group (LON: CTEC) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 10,000 employees.

The shares were at 268.20 GBp on 19 November 2026, up 13.4% over 52 weeks.

At a market capitalisation of 5.12B GBP, it trades at 53.6 times trailing earnings and 15.6 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, so CTEC is valued in line with them. It pays a dividend yielding 2.05% (it pays out 116% of its earnings), against a median of 0.93% among the dividend payers in that peer group.

Convatec Group reports return on equity of 11.5%, an operating margin of 16.3% and revenue up 4.4% year over year.

Its debt exceeds its cash by 1.65B USD, a debt-to-equity ratio of 1.00. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 20 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 312.99 GBp is 16.7% above the current price. The next earnings report is expected on 23 February 2027.